Related Experiment Video
Updated: Jun 20, 2026

Quantifying Glomerular Permeability of Fluorescent Macromolecules Using 2-Photon Microscopy in Munich Wistar Rats
Published on: April 17, 2013
[Microalbuminuria and albuminuria: differential diagnosis and consequences for treatment]
M J Koziolek1, C P Bramlage, R Vasko
1Abteilung Nephrologie und Rheumatologie, Georg-August-Universität Göttingen. mkoziolek@med.uni-goettingen.de
Abstract:
The occurrence of microalbuminuria or albuminuria indicates a disturbance of the barrier function of endothelial cells, basement membrane or of a structural-renal disease (including diseased podocytes). The prevalence of microalbuminuria in the general population is about 8 %, however, in high risk groups, prevalence rates of 50 % and more have been observed. Its incidence is strongly associated with increased cardiovascular morbidity and mortality. Blood pressure control and the blockade of the renin-angiotensin-aldosteron-system (RAAS), respectively, is the central mechanism to reduce cardio-vascular-renal end points as well as mortality.
Insights
Microalbuminuria signals kidney or endothelial dysfunction, affecting 8% of the population and over 50% in high-risk groups. Managing blood pressure and blocking the renin-angiotensin-aldosterone system (RAAS) is key to reducing cardiovascular and kidney disease risks.
Area of Science:
- Nephrology
- Cardiology
- Endocrinology
Context:
- Microalbuminuria indicates impaired kidney barrier function.
- Prevalence is 8% generally, but >50% in high-risk populations.
- Associated with significant cardiovascular morbidity and mortality.
Purpose:
- To highlight the significance of microalbuminuria as a marker.
- To emphasize the link between microalbuminuria and cardiovascular/renal outcomes.
- To underscore the importance of RAAS blockade and blood pressure control.
Summary:
- Microalbuminuria signifies endothelial or structural renal disease.
- High prevalence in specific groups warrants attention.
- Strongly linked to increased cardiovascular and mortality risks.
Impact:
- Highlights the critical role of blood pressure management.
- Emphasizes renin-angiotensin-aldosterone system (RAAS) blockade for cardio-renal protection.
- Provides insights into reducing cardiovascular and renal end points and mortality.
Related Concept Videos
Diabetic Nephropathy
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome II : Assessment and Medical Management
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Nephrotic Syndrome III : Nursing Management

